141 related articles for article (PubMed ID: 33407979)
1. Incidence of neurodegenerative and cerebrovascular diseases associated with antihypertensive drug classes.
Harrison PJ; Colbourne L; Luciano S
Br J Psychiatry; 2021 May; 218(5):283-285. PubMed ID: 33407979
[TBL] [Abstract][Full Text] [Related]
2. Beta-blockers for hypertension.
Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
[TBL] [Abstract][Full Text] [Related]
3. Rates of delirium associated with calcium channel blockers compared to diuretics, renin-angiotensin system agents and beta-blockers: An electronic health records network study.
Harrison PJ; Luciano S; Colbourne L
J Psychopharmacol; 2020 Aug; 34(8):848-855. PubMed ID: 32638634
[TBL] [Abstract][Full Text] [Related]
4. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
[TBL] [Abstract][Full Text] [Related]
5. Onset and recurrence of psychiatric disorders associated with anti-hypertensive drug classes.
Colbourne L; Luciano S; Harrison PJ
Transl Psychiatry; 2021 May; 11(1):319. PubMed ID: 34039956
[TBL] [Abstract][Full Text] [Related]
6. Calcium channel blockers versus other classes of drugs for hypertension.
Chen N; Zhou M; Yang M; Guo J; Zhu C; Yang J; Wang Y; Yang X; He L
Cochrane Database Syst Rev; 2010 Aug; (8):CD003654. PubMed ID: 20687074
[TBL] [Abstract][Full Text] [Related]
7. Beta-blockers for hypertension.
Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Opie LH
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002003. PubMed ID: 28107561
[TBL] [Abstract][Full Text] [Related]
8. Brain-penetrant calcium channel blockers are associated with a reduced incidence of neuropsychiatric disorders.
Colbourne L; Harrison PJ
Mol Psychiatry; 2022 Sep; 27(9):3904-3912. PubMed ID: 35618884
[TBL] [Abstract][Full Text] [Related]
9. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
10. Comparative risk of new-onset diabetes mellitus for antihypertensive drugs in elderly: A Bayesian network meta-analysis.
Zhang J; Tong A; Dai Y; Niu J; Yu F; Xu F
J Clin Hypertens (Greenwich); 2019 Aug; 21(8):1082-1090. PubMed ID: 31241860
[TBL] [Abstract][Full Text] [Related]
11. The effects of calcium channel blockers in the prevention of stroke in adults with hypertension: a meta-analysis of data from 273,543 participants in 31 randomized controlled trials.
Chen GJ; Yang MS
PLoS One; 2013; 8(3):e57854. PubMed ID: 23483932
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Calcium Channel Blockers Versus Other Classes of Antihypertensive Medication in the Treatment of Hypertensive Patients With Previous Stroke and/or Coronary Artery Disease: A Systematic Review and Meta-Analysis.
Jeffers BW; Robbins J; Bhambri R
Am J Ther; 2017; 24(1):e68-e80. PubMed ID: 26588586
[TBL] [Abstract][Full Text] [Related]
13. Beta-blockers for hypertension.
Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Mbewu A; Opie LH
Cochrane Database Syst Rev; 2012 Nov; 11():CD002003. PubMed ID: 23152211
[TBL] [Abstract][Full Text] [Related]
14. Beta-blockers for hypertension.
Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Mbewu A; Opie LH
Cochrane Database Syst Rev; 2012 Aug; (8):CD002003. PubMed ID: 22895924
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive Medication Classes and the Risk of Dementia: A Systematic Review and Network Meta-Analysis.
den Brok MGHE; van Dalen JW; Abdulrahman H; Larson EB; van Middelaar T; van Gool WA; van Charante EPM; Richard E
J Am Med Dir Assoc; 2021 Jul; 22(7):1386-1395.e15. PubMed ID: 33460618
[TBL] [Abstract][Full Text] [Related]
16. How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis.
Bradley HA; Wiysonge CS; Volmink JA; Mayosi BM; Opie LH
J Hypertens; 2006 Nov; 24(11):2131-41. PubMed ID: 17053529
[TBL] [Abstract][Full Text] [Related]
17. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
18. Lower dementia risk with different classes of antihypertensive medication in older patients.
van Middelaar T; van Vught LA; Moll van Charante EP; Eurelings LSM; Ligthart SA; van Dalen JW; van den Born BJH; Richard E; van Gool WA
J Hypertens; 2017 Oct; 35(10):2095-2101. PubMed ID: 28509727
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive drug classes have different effects on short-term blood pressure variability in essential hypertension.
Levi-Marpillat N; Macquin-Mavier I; Tropeano AI; Parati G; Maison P
Hypertens Res; 2014 Jun; 37(6):585-90. PubMed ID: 24671016
[TBL] [Abstract][Full Text] [Related]
20. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
Fu EL; Clase CM; Evans M; Lindholm B; Rotmans JI; Dekker FW; van Diepen M; Carrero JJ
Am J Kidney Dis; 2021 May; 77(5):719-729.e1. PubMed ID: 33246024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]